China Sickle Cell Disease Drugs Market Analysis

China Sickle Cell Disease Drugs Market Analysis


$ 3999

This report presents a strategic analysis of the China Sickle Cell Disease Drugs Market Analysis and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Sickle Cell Disease Drugs Market Analysis, offering unmatched value, accuracy, and expert insights.

ID: IN10CNPH559 CATEGORY: Pharmaceuticals GEOGRAPHY: China

Buy Now

China Sickle Cell Disease Drugs Market Analysis Executive Summary

Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. Numerous consequences result from it, including acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). Currently, doctors frequently recommend bone marrow and blood transplants to treat SCD. It entails removing the damaged bone marrow and replacing it with healthy bone marrow obtained from a donor. As they can lessen particular symptoms and extend patients' lives, other efficient treatments including pharmaceuticals and blood transfusions are also being used.

Market Size and Key Findings

The China Sickle Cell Disease Drugs Market Analysis size is around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.

China Sickle Cell Disease Drugs Market Analysis Size (In $Bn)

(2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

One of the important reasons driving the demand for new pharmaceuticals that can effectively treat the condition is the huge rise in the number of people with SCD. As a result, the health regulatory agencies of many nations are concentrating on expediting the licensing of new treatment modalities. For instance, in 2019 the US Food and Drug Administration (USFDA) approved a novel drug to lessen the pain that both adults and children with SCD feel. Additionally, government agencies are funding research and development (R&D) initiatives to motivate academics and pharmaceutical firms to create innovative therapies. For instance, scientists at the National Heart, Lung, and Blood Institute (NHLBI) in the US are developing genetic medicines that can replace a gene that has been lost or add a new DNA strain to enhance cellular function. It is projected that these advances would help fuel market expansion, combined with rising disposable incomes and increased consumer awareness of healthcare options.

Market Restraints

The high expense of treating sickle cell illness and its adverse effects, which include headache, nausea, diarrhea, exhaustion, rash, and fever, are anticipated to restrain the market for treatments for sickle cell disease. 

Competitive Landscape

Key Players

Some of the key companies are Agios Pharmaceuticals, Bristol-Myers Squibb, CRISPR Therapeutics, editas Medicine, Emmaus Life Sciences, Inc., Global Blood Therapeutics, Inc., Medunic USA Inc., Novartis AG, Novo Nordisk, Vifor Pharma

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

China Sickle Cell Drug Market Segmentation

By Type (Revenue, USD Billion):

The market is divided based on type into HbSS, also known as sickle cell anemia, HbSC, and others (HbS beta thalassemia, HbSD, HbSE, and HbSO). Due to the rise in complications associated with sickle cell anemia, such as hemolysis and vaso-occlusive crisis, the sickle cell anemia segment generated the most revenue in 2021 and is anticipated to maintain its dominance during the forecast period for the sickle cell disease treatment market.

  • Sickle Cell Anemia
  • HbSC
  • Others

By Drug Type (Revenue, USD Billion):

The market is divided into hydroxyurea, oxbryta, adakveo, and other categories depending on the type of medicine. In 2021, the global market for treating sickle cell disease was dominated by the hydroxyurea segment. The rise of the category is fueled by hydroxyurea, which is an excellent treatment option for sickle cell anemia and offers therapeutic benefits through numerous mechanisms of action. However, it is anticipated that during the forecast period, the adakveo category will increase at the quickest rate. This is due to an increase in the use of the medicine Adakveo for the treatment of the vaso-occlusive crisis (VOC) caused by sickle cell illness, which will cause demand for Adakveo to increase throughout the forecast period.

  • Hydroxyurea
    • 4.2.1.1 Distribution Channel
      • Hospitals Pharmacies
      • Drug Stores and Retail Pharmacies
      • Online Providers
  • Oxybryta
  • Adakveo
  • Others

By Route of Administration (Revenue, USD Billion):

The market is divided into oral and parenteral segments based on the route of administration. The oral segment generated the most revenue in 2021 as a result of the widespread use of oral medications due to their noninvasive nature, high patient compliance, portability, and lack of any special sterile requirements.

  • Oral
  • Parenteral

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 January 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up